MENU
LQDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Liquidia (LQDA) Ownership - Who owns Liquidia?

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

Profile

Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.11B
P/E Ratio
N/A
Total Cash
157.5M
Projected Growth
N/A
Total Debt
199.18M
Revenue
69.22M
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash/Share
1.81
Total Debt/Equity
N/A
Revenue/Share
0.81 USD as % of share price

Fundamentals

LQDA
Capitalization
3.11B
P/E Ratio
N/A
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash
157M
Total Cash/Share
1.81
Total Debt
199M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.81%
Revenue
69.2M
ROE
N/A
Book Value
22.1M
P/B Ratio
140.85
Cash Flow
N/A
Earnings
-1.46
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
87K
Current Ratio
2.20
Current Revenue Per Employee
319658.80
Dividends Per Share - Security
N/A
EBITDA
-102.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.16
Revenue To Assets
-46.93
Shares Held By Institutions
1.75B
Shares Outstanding - Current
87M
Total Liabilities
254M
Total Volume MTD
N/A
Value
-1
Gain YTD
204.337
View a ticker or compare two or three
LQDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LQDA showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com